WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that the company will participate at the 43rd Annual Meeting of the Drug Information Association (DIA), June 17-21 in Atlanta, Ga. Company executives will discuss several key topics relating to clinical trial data management including electronic health records (EHR), safety signal detection, CDISC and IT interoperability. Session details are as follows:
